Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening guidelines for colorectal cancer.

J H Bond1

  • 1Veterans Affairs Medical Center, Minneapolis, Minnesota 55417, USA.

The American Journal of Medicine
|March 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for severe delayed postpolypectomy bleeding.

Endoscopy·2008
Same author

FOBT is not an effective way to screen for gastric cancer.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2007
Same author

Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group.

Gut·2005
Same author

Colon polyps and cancer.

Endoscopy·2005
Same author

Update on colorectal polyps: management and follow-up surveillance.

Endoscopy·2003
Same author

Colon polyps and cancer.

Endoscopy·2003

Regular colorectal cancer screening for individuals over 50 can significantly reduce mortality. Current guidelines suggest fecal occult blood tests annually combined with flexible sigmoidoscopy every five years.

Area of Science:

  • Gastroenterology
  • Preventive Medicine
  • Oncology

Background:

  • Colorectal cancer screening is recommended for asymptomatic, average-risk U.S. citizens over 50.
  • Higher-risk individuals require more intensive screening and surveillance.
  • Effective screening can decrease colorectal cancer mortality by over 50%.

Purpose of the Study:

  • To summarize evidence-based guidelines for colorectal cancer screening.
  • To outline current recommended screening methods and future possibilities.

Main Methods:

  • Review of evidence-based guidelines for colorectal cancer screening.
  • Evaluation of directly tested screening methods: fecal occult blood test and flexible sigmoidoscopy.
  • Consideration of indirectly supported methods (colonoscopy, barium enema) and emerging technologies (gene-based tests, virtual colonoscopy).

Related Experiment Videos

Main Results:

  • Annual fecal occult blood testing plus flexible sigmoidoscopy every 5 years is recommended for average-risk individuals over 50.
  • Colonoscopy and barium enema are supported by indirect evidence for motivated individuals.
  • Future screening may involve gene-based tests or virtual colonoscopy.

Conclusions:

  • Adherence to screening guidelines can substantially reduce colorectal cancer mortality.
  • A combination of fecal occult blood testing and flexible sigmoidoscopy is a primary recommended screening strategy.
  • Ongoing research into new screening technologies holds promise for improved detection and prevention.